How should healthcare organisations govern vendor-of-vendor risk?

Why This Matters for Security Teams

Vendor-of-vendor risk is not a procurement footnote in healthcare. It is a direct operational and patient-safety issue because subcontractors, hosting providers, billing platforms, and managed service layers can hold data, influence uptime, or inherit access that your team never approved explicitly. Current guidance suggests organisations should treat the full dependency chain as part of the attack surface, not just the signed master contract. That framing aligns with the NIST Cybersecurity Framework 2.0 and the supply chain emphasis in Ultimate Guide to NHIs — Key Challenges and Risks.

Healthcare teams often underestimate how many indirect parties can touch protected health information, authentication flows, or clinical availability. That creates blind spots in breach notification timing, business continuity planning, and access review. NHIMG research shows that 92% of organisations expose NHIs to third parties, which is a useful signal that vendor chains commonly extend beyond the first-tier supplier and into hidden identity and secret-sharing paths. In practice, many security teams encounter third-party exposure only after a outage, audit request, or incident notification has already forced the dependency map into the open.

How It Works in Practice

Governance starts by documenting each critical service and then tracing every dependency that could affect confidentiality, integrity, availability, or recovery. For healthcare, that means asking which subcontractors process data, which platforms host workloads, which support entities can reset access, and which service accounts or secrets are shared across the chain. The goal is not just inventory. It is decision-grade visibility.

A practical control set usually includes four steps:

• Require named disclosure of subcontractors, hosting providers, and administrative intermediaries before onboarding and at each material change.
• Require evidence of recovery capability, including backup scope, restoration testing, and failover ownership for indirect providers.
• Contract for notification timelines that are at least as fast as your own regulatory reporting duties, including incidents at downstream suppliers.
• Map where identities, secrets, and support access are held so that a third party cannot introduce unmanaged privilege into your environment.

This is where healthcare-specific assurance becomes important. A supplier may be secure at the contract boundary while a subcontractor quietly holds production access, an API key, or replicated patient data. The Ultimate Guide to NHIs — Lifecycle Processes for Managing NHIs is useful here because lifecycle control, not just initial approval, determines whether access remains justified over time. The CSA Cloud Controls Matrix also helps structure supplier questions around shared responsibility, logging, and resilience expectations.

Security and legal teams should align on escalation paths, evidence collection, and audit rights before the first incident. These controls tend to break down when a vendor refuses to disclose downstream processors because the organisation has no contractual leverage after go-live.

Common Variations and Edge Cases

Tighter vendor oversight often increases procurement friction and renewal overhead, so organisations must balance visibility against onboarding speed and clinical continuity. There is no universal standard for this yet, especially where global suppliers use layered hosting, regional support desks, or platform marketplaces that change frequently.

One common edge case is a software provider that outsources hosting and support but insists it has no “subprocessors” in the traditional sense. Another is a medical device or clinical workflow service where the indirect provider controls firmware, telemetry, or remote maintenance access. In both cases, the security question is the same: who can actually change, read, route, or restore the service?

Healthcare organisations should treat indirect access and indirect data handling as material if either one can affect patient care, privacy, or breach reporting. NHIMG notes that only 5.7% of organisations have full visibility into their service accounts, which helps explain why indirect supplier identities are often missed during due diligence. Best practice is evolving, but the direction is clear: if the supplier chain cannot be evidenced, it should not be assumed safe.

Related resources from NHI Mgmt Group

• When should organisations treat an NHI as a high-priority risk?
• How should organisations govern third-party access in a vendor risk policy?
• How should healthcare organisations govern privileged vendor access?
• How should organisations govern remote access for HPC environments?